Multiorgan Quantitative T1 Mapping In Systemic Inflammation: Difference between revisions
No edit summary |
|||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[Category:Accepted_MS_2025]] | |||
<!-- | <!-- | ||
| Line 12: | Line 14: | ||
{{Member Session | {{Member Session | ||
| title= Multiorgan Quantitative T1 Mapping | | title= Multiorgan Quantitative T1 Mapping: Advances in Thoraco-Abdominal Tissue Characterization | ||
| short_text= This session explores the | | short_text= This session explores the current applications of quantitative T1 mapping for tissue characterization in thoraco-abdominal organs. We will examine how this MRI technique enables non-invasive assessment of tissue properties through T1 relaxation time measurements, including mechanisms underlying T1 changes in different pathological states. The session addresses standardization of acquisition protocols, analysis methods, and clinical validation studies in the heart, liver, pancreas and kidneys. Special attention will be given to the biological basis of T1 alterations in different tissue types, from fibrosis to inflammatory changes. Through perspectives from physics, radiology, and clinical practice, we aim to critically assess both the established applications and emerging opportunities of T1 mapping as a quantitative imaging biomarker. | ||
| duration= 60m | | duration= 60m | ||
| audience= Physicists, Radiologists | | audience= Physicists, Radiologists | ||
| Moderators= | | Moderators= Michele Pansini, MD | ||
| Moderators_Confirmed= | | Moderators_Confirmed= Yes | ||
| Speaker1= Matt Robson | | Speaker1= Matt Robson Prof. Dr. | ||
| Speaker1_Confirmed= Yes | | Speaker1_Confirmed= Yes | ||
| Speaker2= | | Speaker2= Giovanni Morana Prof. Dr. | ||
| Speaker2_Confirmed= | | Speaker2_Confirmed= Yes | ||
| Speaker3= | | Speaker3= Dan Cuthbertson Prof. BSc (Hons) PhD FRCP | ||
| Speaker3_Confirmed= | | Speaker3_Confirmed= Yes | ||
}} | }} | ||
| Line 30: | Line 32: | ||
== Session description == | == Session description == | ||
This session will | This session will explore quantitative T1 mapping for thoracoabdominal tissue characterization. The technique enables non-invasive assessment of tissue properties in the heart, liver, pancreas and kidneys, with a focus on biological mechanisms, standardization, validation, and clinical implementation. | ||
The program will be the following: | The program will be the following: | ||
* Introduction by | * Introduction by Michele Pansini ''(5 min)'': overview of the session goals and relevance of T1 mapping in thoracoabdominal tissue characterization | ||
* Presentation by Matt Robson ''(15 min)'': technical foundations and standardization of T1 mapping protocols across multiple organs | * Presentation by Matt Robson ''(15 min)'': technical foundations and standardization of T1 mapping protocols across multiple organs | ||
* Presentation by | * Presentation by Giovanni Morana ''(15 min)'': radiological perspective on T1 mapping analysis and biological mechanisms in different tissue types | ||
* Presentation by | * Presentation by Dan Cuthbertson ''(15 min)'': established clinical applications and emerging uses in disease monitoring and treatment response | ||
* Questions and Answers ''(10 min)'' | * Questions and Answers ''(10 min)'' | ||
Latest revision as of 13:12, 10 October 2025
Multiorgan Quantitative T1 Mapping: Advances in Thoraco-Abdominal Tissue Characterization
This session explores the current applications of quantitative T1 mapping for tissue characterization in thoraco-abdominal organs. We will examine how this MRI technique enables non-invasive assessment of tissue properties through T1 relaxation time measurements, including mechanisms underlying T1 changes in different pathological states. The session addresses standardization of acquisition protocols, analysis methods, and clinical validation studies in the heart, liver, pancreas and kidneys. Special attention will be given to the biological basis of T1 alterations in different tissue types, from fibrosis to inflammatory changes. Through perspectives from physics, radiology, and clinical practice, we aim to critically assess both the established applications and emerging opportunities of T1 mapping as a quantitative imaging biomarker.
| Session duration: | 60m |
| Intended audience: | Physicists, Radiologists |
| Moderators: | Michele Pansini, MD (Confirmed: Yes) |
| First Speaker: | Matt Robson Prof. Dr. (Confirmed: Yes) |
| Second Speaker: | Giovanni Morana Prof. Dr. (Confirmed: Yes) |
| Third Speaker: | Dan Cuthbertson Prof. BSc (Hons) PhD FRCP (Confirmed: Yes) |
Session description
This session will explore quantitative T1 mapping for thoracoabdominal tissue characterization. The technique enables non-invasive assessment of tissue properties in the heart, liver, pancreas and kidneys, with a focus on biological mechanisms, standardization, validation, and clinical implementation.
The program will be the following:
- Introduction by Michele Pansini (5 min): overview of the session goals and relevance of T1 mapping in thoracoabdominal tissue characterization
- Presentation by Matt Robson (15 min): technical foundations and standardization of T1 mapping protocols across multiple organs
- Presentation by Giovanni Morana (15 min): radiological perspective on T1 mapping analysis and biological mechanisms in different tissue types
- Presentation by Dan Cuthbertson (15 min): established clinical applications and emerging uses in disease monitoring and treatment response
- Questions and Answers (10 min)